The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey (Sprit)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2012 by Chinese Medical Doctor Association.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Lin Shen,MD & Ruihua Xu,MD、PhD, Chinese Medical Doctor Association
ClinicalTrials.gov Identifier:
NCT01549067
First received: March 6, 2012
Last updated: March 13, 2012
Last verified: March 2012
  Purpose

Collect the real clinical background of advanced colorectal cancer c of China.


Condition
Advanced Malignant Neoplasm
Colorectal Cancer

Study Type: Observational
Study Design: Time Perspective: Cross-Sectional
Official Title: The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey

Resource links provided by NLM:


Further study details as provided by Chinese Medical Doctor Association:

Estimated Enrollment: 3700
Study Start Date: September 2011
Estimated Study Completion Date: December 2012
Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
Detailed Description:

The Primary Objectives of this study is collect the real clinical background of advanced colorectal cancer treatment situation of China. The Secondary Objectives is the mutation of K-ras , targeting therapy , use present situation of cetuximab and liver metastases treatment situation of colorectal cancer patients.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Advanced Colorectal Cancer

Criteria

Inclusion Criteria:

  • Patients with histologically or cytologically confirmed diagnosis of metastatic colorectal cancer.

Exclusion Criteria:

  • Patients with histologically or cytologically confirmed diagnosis other than metastatic colorectal cancer.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01549067

Contacts
Contact: Lin Shen, MD 010-88140650 lin100@medmail.com.cn
Contact: Rui-hua Xu, MD , PhD 020-87343468 xurh@sysucc.org.cn

Locations
China, Beijing
Peking University Cancer Hospital Recruiting
Beijing, Beijing, China
Contact: Lin Shen, MD    010-88140650    lin100@medmail.com.cn   
Principal Investigator: Lin Shen, MD         
China, Guangzhou
Sun Yat-sen University Cancer Center Recruiting
Zhongshan, Guangzhou, China
Contact: Rui-hua Xu, MD , PhD    020-87343468    xurh@sysucc.org.cn   
Principal Investigator: Rui-hua Xu, MD , PhD         
Sponsors and Collaborators
Chinese Medical Doctor Association
Investigators
Principal Investigator: Lin Shen, MD Beijing Cancer Hospital
Principal Investigator: Ruihua Xu, MD, PhD Sun Yat-sen University
  More Information

No publications provided

Responsible Party: Lin Shen,MD & Ruihua Xu,MD、PhD, Principal Investigator, Chinese Medical Doctor Association
ClinicalTrials.gov Identifier: NCT01549067     History of Changes
Other Study ID Numbers: Sprit
Study First Received: March 6, 2012
Last Updated: March 13, 2012
Health Authority: China: Ethics Committee

Keywords provided by Chinese Medical Doctor Association:
Advanced
Colorectal Cancer
Targeted chemotherapy
Surgery
Radiotherapy

Additional relevant MeSH terms:
Neoplasms
Colorectal Neoplasms
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Digestive System Diseases
Gastrointestinal Diseases
Colonic Diseases
Intestinal Diseases
Rectal Diseases

ClinicalTrials.gov processed this record on July 22, 2014